EPHB4 and lung carcinoma: Although EphB4 has traditionally been considered to be primarily an effector of cytoskeletal rearrangement and therefore cellular motility, these data, taken together with the pro-proliferative findings, suggest that the primary roles of EphB4 in lung cancer cells may involve both cellular survival and movement.